Results 191 to 200 of about 132,395 (346)

Outsourced eye care in the Finnish capital region: Switching from fee‐for‐service to bundled payment model

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page 114-129, February 2026.
Abstract Purpose The demand for specialised eye care has quadrupled over the last two decades, driven by an aging population and the advent of new treatments. This surge has led to increased outsourcing by the Helsinki and Uusimaa Hospital District (HUS) Eye Hospital, initially relying on a fee‐for‐service model. This model, however, has been marked by
Susanna Moisander   +7 more
wiley   +1 more source

2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations

open access: yesOphthalmologica, 2018
A. Grzybowski   +6 more
semanticscholar   +1 more source

Intravitreal anti‐vascular endothelial growth factor injections and risks of stroke in patients with neovascular age‐related macular degeneration—A registry‐based cohort study

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page 98-105, February 2026.
Abstract Background Intravitreal Anti‐Vascular Endothelial Growth Factor (VEGF) rescues retinal vasculatures and prevents disease progression in patients with neovascular Age‐Related Macular Degeneration (nAMD). However, systemic anti‐VEGF may increase the risk of thromboembolic related complications including stroke and TIA. This study aims to explore
A. H. Falemban   +5 more
wiley   +1 more source

Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema [PDF]

open access: bronze, 2017
Dilsher S. Dhoot   +7 more
openalex   +1 more source

A 66‐year‐old man with acute retinal necrosis

open access: yes
Brain Pathology, Volume 36, Issue 2, March 2026.
Shino Magaki   +3 more
wiley   +1 more source

Impact of anti‐VEGF therapy versus laser therapy on mortality and treatment outcomes in retinopathy of prematurity: A systematic review and meta‐analysis

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page e1-e17, February 2026.
Abstract Purpose Retinopathy of prematurity (ROP) is a major cause of childhood blindness, and selecting the optimal treatment between anti‐vascular endothelial growth factor (anti‐VEGF) and laser therapy is crucial. Understanding their impact on key outcomes, particularly mortality, is essential for informed clinical decision‐making.
Wei‐De Wang   +10 more
wiley   +1 more source

Continuity of care and risk of vision loss in patients with newly developed macular degeneration

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page e39-e47, February 2026.
Abstract Purpose Neovascular age‐related macular degeneration (AMD) is a major cause of vision loss. Effective treatment requires sustained care, which may be influenced by continuity of care (COC). Understanding this association is crucial for improving patient outcomes.
In Hwan Cho   +5 more
wiley   +1 more source

Intravitreal anti-VEGF agents – The way forward

open access: hybrid, 2022
Sabyasachi Sengupta, Vishal Raval
openalex   +1 more source

Home - About - Disclaimer - Privacy